Electroceuticals gaining in popularity: Swapping drugs for devices to treat depression

Soterix Medical received CE Mark approval for its transcranial direct current stimulation (tDCS) depression therapy in late December 2015. TDCS Therapy is a non-invasive therapeutic device that delivers low-intensity direct current to a region of the cerebral cortex, the part of the brain that co...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Diabetes platform Glooko raises $30 million, looks to branch into additional therapy areas

News Commentary | March 29, 2021

The round was led by Health Catalyst Capital, with previous investors like Novo Nordisk, Insulet, and Mayo Clinic also participating. Glooko has had success in recent years with its diabetes monitoring platform, which connects therapy devices to healthcare providers. The company plans on using the ... Not part of subscription

Biofourmis and Chugai look toward digital women's health, partnering to develop biomarkers for endometriosis

Case Study | April 20, 2021

In 2020, Biofourmis and Chugai Pharmaceutical partnered to develop an analytics platform for quantifying pain associated with endometriosis. Biofourmis is a global leader in AI‑driven digital therapeutics, and Chugai is a leading Japanese pharmaceutical research company. The platform consists of a ... Not part of subscription

Royal Philips begins clinical trials for first at-home ECG solution

News Commentary | February 07, 2022

Philips' device will be the industry's first attempt at an at‑home, 12‑lead ECG (electrocardiogram). It will include access to Philips' cardiac monitoring portfolio, which pairs cloud‑based data collection with data readings it claims are comparable to clinical ECGs. While the solution is still in ... Not part of subscription